Latest from Arrajol
Yahoo
14 minutes ago
- General
- Yahoo
Qantas plane makes sudden landing
A Qantas plane with more than 60 passengers on board has been forced to make a priority landing in western Victoria due to a 'technical issue'. The QF2079 flight was scheduled for 10.40am on Tuesday, travelling from Mildura to Melbourne, when the aircraft had to make a sudden landing with 63 passengers on board. A Qantas spokesman said 'one of our (aircraft) had to return to Mildura shortly after takeoff on Tuesday due to a technical issue'. 'Our pilots are highly trained to handle situations like this, and the flight has since landed safely in Mildura,' a Qantas statement read. 'We appreciate this would have been an unsettling experience for customers and thank them for their understanding.' Police were called to Mildura Airport just after 11am following reports of an 'aircraft incident'. 'Police along with other emergency services were called to an airport in Mildura following reports of an aircraft incident just after 11am, where it appears there was an issue with the aircraft,' police told NewsWire. 'The plane landed safely, pilot and passengers weren't injured.' Ambulance Victoria also confirmed crews were called to the scene about 11am. 'No emergency treatment or transport was provided,' they said. An Australian Transport Safety Bureau spokesman told NewsWire the ATSB was aware of the incident. 'The ATSB has been notified of a Dash 8 passenger airliner return to Mildura this morning due to a technical issue, and is gathering further information prior to making an investigation decision,' the spokesman said. More to come
Yahoo
14 minutes ago
- Automotive
- Yahoo
Uber to Roll Out 20,000 Lucid Gravity Robotaxis with Nuro Self-Driving Tech
Lucid Group (LCID, Financials) is going driverless and it's doing it in style. The EV maker has inked a game-changing partnership with Uber (UBER, Financials) and autonomous tech firm Nuro to launch a global fleet of robotaxis starting next year. Warning! GuruFocus has detected 4 Warning Signs with LCID. The alliance is a first-of-its-kind mashup: Lucid's Gravity SUV, Nuro's Level 4 self-driving system, and Uber's rideshare muscle all wrapped into a premium autonomous experience, purpose-built for the Uber app. The rollout kicks off in 2026 with 20,000 Lucid Gravity vehicles planned over six years. Uber is backing the move with a $300 million investment in Lucid and an undisclosed amount in Nuro. The prototype Gravity robotaxi is already up and running at Nuro's Las Vegas proving grounds, operating fully autonomously on a test track. Lucid's interim CEO Marc Winterhoff called the partnership a validation of the company's fully redundant zonal architecture and said the deal puts Lucid at the forefront of a multi-trillion-dollar autonomous mobility market. This is only the beginning, Winterhoff said. The robotaxis will be operated and maintained by Uber and its partners, available exclusively through the Uber app. While the first wave will feature Lucid Gravity SUVs, the companies hinted that Lucid's upcoming midsize EVs may be added later. The announcement comes at a pivotal moment for Lucid. With production finally ramping, record Q2 deliveries, and plans for more affordable EVs, this alliance could cement its place in the next phase of electric mobility with no drivers required. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 minutes ago
- Business
- Yahoo
Molina Healthcare (MOH) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare insurance company Molina Healthcare (NYSE:MOH) will be reporting earnings this Wednesday afternoon. Here's what investors should know. Molina Healthcare beat analysts' revenue expectations by 2.6% last quarter, reporting revenues of $11.15 billion, up 12.2% year on year. It was a satisfactory quarter for the company, with a decent beat of analysts' EPS estimates but customer base in line with analysts' estimates. It added 217,000 customers to reach a total of 5.75 million. Is Molina Healthcare a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Molina Healthcare's revenue to grow 10.8% year on year to $10.95 billion, slowing from the 18.7% increase it recorded in the same quarter last year. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Molina Healthcare has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 3.2% on average. Looking at Molina Healthcare's peers in the healthcare providers & services segment, only Elevance Health has reported results so far. It beat analysts' revenue estimates by 3%, delivering year-on-year sales growth of 13.4%. The stock was down 19.7% on the results. Read our full analysis of Elevance Health's earnings results here. Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.1% on average over the last month. Molina Healthcare is down 39.5% during the same time. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
14 minutes ago
- Entertainment
- Yahoo
Cutest Back-to-School Handprint Craft You'll Want to Save Forever
This Back-to-School Handprint Printable is the perfect keepsake craft for kids! A fun way to celebrate the new school year and get kids excited for the big day. Handprint crafts are always a fun idea! Since the school year is starting or may have already started, now is the time to start this fun art project! The kids will love making something like this – and being able to use their hands as well! Messy play is always a great way to keep their attention and keep them involved. Not only will they use their hands as the stem of the apple, but they'll also have a forever keepsake to remember their first day of school! This is the perfect activity that is also a great keepsake for them to have as they get older! What is a fun way to use this Handprint Art Back to School Printable? This would be super cute to have the kids hold up for their first day at school picture. Every parent makes the kids pose and smile on their first day, so holding this printable just seems like a great idea! Handprint Art Back to School Printable – Supplies Back to School Apple Printable Green paint Paintbrush How long does it take the paint to dry? Since you're not putting a heavy coating of paint on the paper, it shouldn't take long at all. Just touch it lightly with your finger – and if it's wet, give it more time to dry. Make sure that it's dried all the way before having the kids hold it for the picture or putting it in a frame. Instructions Start by printing out the back to school PDF template Paint your child's hand green and then put it on top of the apple to make the stem! Final Thoughts This apple handprint craft is such a fun way to kick off the school year. It's simple, meaningful, and makes a cute keepsake you'll cherish for years. Happy crafting and happy back-to-school season!
Yahoo
14 minutes ago
- Business
- Yahoo
What To Expect From Boston Scientific's (BSX) Q2 Earnings
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday before market hours. Here's what you need to know. Boston Scientific beat analysts' revenue expectations by 2% last quarter, reporting revenues of $4.66 billion, up 20.9% year on year. It was a very strong quarter for the company, with a solid beat of analysts' organic revenue estimates and a solid beat of analysts' EPS estimates. Is Boston Scientific a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Boston Scientific's revenue to grow 18.8% year on year to $4.89 billion, improving from the 14.5% increase it recorded in the same quarter last year. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Boston Scientific has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 3.1% on average. Looking at Boston Scientific's peers in the healthcare equipment and supplies segment, only Abbott Laboratories has reported results so far. It beat analysts' revenue estimates by 0.9%, delivering year-on-year sales growth of 7.4%. The stock was down 6.1% on the results. Read our full analysis of Abbott Laboratories's earnings results here. Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.1% on average over the last month. Boston Scientific is up 1.5% during the same time. When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
